Christian Drosten

10 ta ish

Charité

AkademScholarda batafsil koʻrsatkichlar

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder +10
Maqola202010 iqtibos
ABI
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman, Olfert Landt, Marco Kaiser +21
MaqolaOchiq kirish20207 iqtibos
ABI
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Julian Braun, Lucie Loyal, Marco Frentsch +30
MaqolaOchiq kirish20203 iqtibos
ABI
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
Jonas Schulte-Schrepping, Nico Reusch, Daniela Paclik +96
MaqolaOchiq kirish20203 iqtibos
ABI
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya, Susan C. Baker, Ralph S. Baric +14
MaqolaOchiq kirish20203 iqtibos
ABI
Virological assessment of hospitalized patients with COVID-2019
Roman Wölfel, Victor M. Corman, Wolfgang Guggemos +15
Maqola20203 iqtibos
ABI
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
Jenny Meinhardt, Josefine Radke, Carsten Dittmayer +40
Maqola20203 iqtibos
ABI
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China
David S.C. Hui, Esam I. Azhar, Tariq A. Madani +9
Tahririyat maqolasi20202 iqtibos
ABI
The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells
Markus Hoffmann, Hannah Kleine‐Weber, Nadine Krüger +3
Preprint20202 iqtibos
ABI
An analysis of SARS-CoV-2 viral load by patient age
Terry C. Jones, Barbara Mühlemann, Talitha Veith +7
Preprint20201 iqtibos
ABI